Kodiak Sciences (KOD) Interest & Investment Income (2018 - 2026)
Kodiak Sciences (KOD) posted Interest & Investment Income of $1.6 million for Q1 2026, up 116.78% on a QoQ basis from $757000.0 in Q4 2025, and up 2.43% year-over-year from $1.6 million in Q1 2025.
Kodiak Sciences (KOD) Interest & Investment Income (2018 - 2026) Analysis & Trends
Kodiak Sciences' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- Quarterly Interest & Investment Income rose 2.43% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 million (down 51.52% YoY) and the FY2025 annual result came in at $4.5 million, down 59.48% from the prior year.
- Interest & Investment Income was $1.6 million for Q1 2026 at Kodiak Sciences, up from $757000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $4.7 million in Q2 2023 and bottomed at $76000.0 in Q1 2022.
- A 5-year average of $2.4 million and a median of $2.5 million in 2022 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 10675.0% — and 2025, when it sank 66.17%.
- Kodiak Sciences' Interest & Investment Income stood at $3.0 million in 2022, then grew by 29.17% to $3.9 million in 2023, then plunged by 45.34% to $2.1 million in 2024, then slumped by 64.46% to $757000.0 in 2025, then jumped by 116.78% to $1.6 million in 2026.
- Business Quant data shows KOD's Interest & Investment Income at $1.6 million in Q1 2026, $757000.0 in Q4 2025, and $917000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Kodiak Sciences | 2.62 Bn | 2.62 Bn | - | 1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 757,000.00 |
| Sep 30, 2025 | 917,000.00 |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.95 Mn |
| Mar 31, 2024 | 3.35 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 4.54 Mn |
| Jun 30, 2023 | 4.68 Mn |
| Mar 31, 2023 | 3.62 Mn |
| Dec 31, 2022 | 3.02 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 76,000.00 |
| Dec 31, 2021 | 28,000.00 |
| Sep 30, 2021 | 40,000.00 |
| Jun 30, 2021 | 81,000.00 |